Dashboard
Manage Tickers

MIRM Mirum Pharmaceuticals, Inc.

Nasdaq mirumpharma.com


$ 69.80 $ 0.12 (0.17 %)    

Tuesday, 04-Nov-2025 18:55:37 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 615.11 $ -4.04 (-0.65 %)
DIA $ 470.25 $ 0.57 (0.12 %)
SPY $ 672.36 $ -0.79 (-0.12 %)
TLT $ 90.13 $ 0.15 (0.17 %)
GLD $ 362.19 $ -1.27 (-0.35 %)
$ 70.97
$ 70.17
$ 64.00 x 25
$ 74.38 x 3
$ 69.75 - $ 72.62
$ 36.88 - $ 78.54
792,599
na
3.65B
$ 0.69
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-07-2025 03-31-2025 10-Q
4 02-26-2025 01-01-1970 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 03-15-2024 12-31-2023 10-K
9 11-02-2023 09-30-2023 10-Q
10 08-07-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 03-08-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-09-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 03-09-2021 12-31-2020 10-K
21 11-12-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 03-12-2020 12-31-2019 10-K
25 11-06-2019 09-30-2019 10-Q
26 08-28-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

mirum-pharmaceuticals-raises-fy2025-sales-guidance-from-490000m-510000m-to-500000m-510000m-vs-505800m-est
Mirum Pharmaceuticals Raises FY2025 Sales ...
11/04/2025 21:03:12

Mirum Pharmaceuticals (NASDAQ:MIRM) raises FY2025 sales outlook from $490.000 million-$510.000 million to $500.000 million-$510...

mirum-pharmaceuticals-q3-eps-005-beats-014-estimate-sales-133010m-beat-130074m-estimate
Mirum Pharmaceuticals Q3 EPS $0.05 Beats $...
11/04/2025 21:02:49

Mirum Pharmaceuticals (NASDAQ:MIRM) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of...

earnings-scheduled-for-november-4-2025
Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

8-analysts-assess-mirum-pharmaceuticals-what-you-need-to-know
8 Analysts Assess Mirum Pharmaceuticals: W...
10/16/2025 20:00:37

morgan-stanley-maintains-overweight-on-mirum-pharmaceuticals-raises-price-target-to-81
Morgan Stanley Maintains Overweight on Mir...
10/16/2025 18:00:33

Morgan Stanley analyst Michael Ulz maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Overweight and raises the price targ...

this-riot-platforms-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This Riot Platforms Analyst Begins Coverag...
09/24/2025 18:35:36

td-cowen-initiates-coverage-on-mirum-pharmaceuticals-with-buy-rating-announces-price-target-of-95
TD Cowen Initiates Coverage On Mirum Pharm...
09/24/2025 16:01:08

TD Cowen analyst Joseph Thome initiates coverage on Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy rating and announces Pric...

demystifying-mirum-pharmaceuticals-insights-from-6-analyst-reviews
Demystifying Mirum Pharmaceuticals: Insigh...
09/12/2025 13:01:47

jp-morgan-maintains-overweight-on-mirum-pharmaceuticals-raises-price-target-to-77
JP Morgan Maintains Overweight on Mirum Ph...
09/12/2025 11:16:31

JP Morgan analyst Jessica Fye maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Overweight and raises the price target fr...

mirum-pharmaceuticals-completes-enrollment-in-phase-2b-vistas-study-topline-data-expected-q2-2026
Mirum Pharmaceuticals Completes Enrollment...
09/08/2025 12:08:48

stifel-reinstates-buy-on-mirum-pharmaceuticals-announces-89-price-target
Stifel Reinstates Buy on Mirum Pharmaceuti...
08/11/2025 11:11:37

Stifel analyst Dae Gon Ha reinstates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and announces $89 price target.

deep-dive-into-mirum-pharmaceuticals-stock-analyst-perspectives-6-ratings
Deep Dive Into Mirum Pharmaceuticals Stock...
08/08/2025 18:02:12

evercore-isi-group-maintains-outperform-on-mirum-pharmaceuticals-raises-price-target-to-89
Evercore ISI Group Maintains Outperform on...
08/08/2025 12:36:21

Evercore ISI Group analyst Gavin Clark-Gartner maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Outperform and raises th...

jmp-securities-maintains-market-outperform-on-mirum-pharmaceuticals-raises-price-target-to-81
JMP Securities Maintains Market Outperform...
08/07/2025 13:36:12

JMP Securities analyst Jonathan Wolleben maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Market Outperform and raises t...

raymond-james-maintains-strong-buy-on-mirum-pharmaceuticals-raises-price-target-to-82
Raymond James Maintains Strong Buy on Miru...
08/07/2025 13:04:37

Raymond James analyst Steven Seedhouse maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Strong Buy and raises the price ...

hc-wainwright--co-maintains-buy-on-mirum-pharmaceuticals-raises-price-target-to-80
HC Wainwright & Co. Maintains Buy on Mirum...
08/07/2025 11:38:37

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and raises t...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/06/2025 21:07:28

mirum-pharmaceuticals-raises-fy2025-sales-guidance-from-435000m-450000m-to-490000m-510000m-vs-448625m-est
Mirum Pharmaceuticals Raises FY2025 Sales ...
08/06/2025 20:03:05

Mirum Pharmaceuticals (NASDAQ:MIRM) raises FY2025 sales outlook from $435.000 million-$450.000 million to $490.000 million-$510...

mirum-pharmaceuticals-q2-eps-012-beats-034-estimate-sales-127785m-beat-107908m-estimate
Mirum Pharmaceuticals Q2 EPS $(0.12) Beats...
08/06/2025 20:02:39

Mirum Pharmaceuticals (NASDAQ:MIRM) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of...

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION